Patients and health workers excited about new HIV treatment
This new regimen will save the Department of Health money and they will now spent R89 a month per patient instead of the R400 on the previous regimen. The new treatment is also expected to improve adherence as the single tablet is easier to take than the multiple tablets.
The first recipient of the drug in Ga-rankuwa was an HIV patient and activist, as well as a member of the Treatment Action Campaign (TAC). He told OurHealth that there is a need to re-educate patients on adherence and reviving adherence clubs (support groups).
He said he hoped that the new drug, which is a combination of Tenofovir, Emtricitabine and Efavirenz, will assist in suppressing the viral load in HIV patients and increase the CD4 count, which will result in a reduction in mortality among children and adults. He urged new patients to adhere to their treatment and praised Tshwaraganang Wellness in Phedisong 4 Clinic for the services they deliver to patients.
Sister Catherine Chimuse, project manager at Tshwaraganang Wellness, told OurHealth that ARV-treatment is increasing, which shows that patients are happy with the drug.
Sister Chimuse said that the new drug works the same as the old regimen, except that patients only need to take one pill, once a day, instead of three pills, twice a day, which makes the treatment simpler and easier to adhere to. – OurHealth/Health-e News Service
Mishack Mahlangu is an OurHealth Citizen Journalist reporting from the Tshwane health district in Gauteng.
Author
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
You must include all of the links from our story, including our newsletter sign up link.
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Patients and health workers excited about new HIV treatment
by Health-e News, Health-e News
April 19, 2013